Department of Nutrition, University of California Davis, Davis, CA, USA.
Division of Community Health Sciences, School of Public Health, University of California Berkeley, Berkeley, CA, USA.
J Nutr. 2020 Apr 1;150(4):958-966. doi: 10.1093/jn/nxz320.
Iron deficiency anemia affects hundreds of millions of women and children worldwide and is associated with impaired infant outcomes. Small-quantity lipid-based nutrient supplement (LNS) have been found to reduce the prevalence of anemia and iron deficiency in some trials.
We evaluated the effectiveness of daily LNS supplementation on child anemia and micronutrient status in Madagascar within the context of an existing, scaled-up nutrition program.
We cluster-randomized 125 communities to (T0) a routine program with monthly growth monitoring and nutrition education; (T1) T0 + home visits for intensive nutrition counselling; (T2) T1 + LNS for children aged 6-18 mo; (T3) T2 + LNS for pregnant/lactating women; or (T4) T1 + parenting messages. Pregnant women and infants aged <12 mo were enrolled in 2014 and followed for 2 y. Child outcome measures included hemoglobin and anemia assessed using the HemoCue 301 system (n = 3561), and serum ferritin and soluble transferrin receptor as markers of iron status, retinol-binding protein as a marker of vitamin A status, and C-reactive protein and α-1 acid glycoprotein from a finger stick blood draw among a subsample (n = 387). We estimated mean difference using linear regression and prevalence ratios using modified Poisson regression accounting for the clustered design. All analyses were intention-to-treat.
Children in the LNS groups (T2 and T3) had ∼40% lower prevalence of anemia and iron deficiency anemia and 25% lower prevalence of iron deficiency than children in the control group (T0) (P < 0.05 for all). There were no differences in any of the biomarkers when comparing children in the T4 group with those in T0; nor were there differences between T3 and T2.
Our findings suggest the provision of LNS in the context of a large-scale program offers significant benefits on anemia and iron status in young children.This trial was registered at www.isrctn.com as ISRCTN14393738.
缺铁性贫血影响着全球数亿妇女和儿童,与婴儿发育受损有关。一些试验发现,小剂量脂质基础营养素补充剂(LNS)可降低贫血和缺铁的发生率。
我们在现有的扩大营养计划范围内,评估在马达加斯加,每天补充 LNS 对儿童贫血和微量营养素状况的影响。
我们采用整群随机方法将 125 个社区分为(T0)常规方案,包括每月生长监测和营养教育;(T1)T0+家访进行强化营养咨询;(T2)T1+6-18 月龄儿童 LNS;(T3)T2+孕妇/哺乳期妇女 LNS;或(T4)T1+育儿信息。2014 年招募孕妇和<12 月龄婴儿,并随访 2 年。儿童结局指标包括血红蛋白和使用 HemoCue 301 系统评估的贫血(n=3561),以及血清铁蛋白和可溶性转铁蛋白受体作为铁状况的标志物、视黄醇结合蛋白作为维生素 A 状况的标志物、以及末梢血样的 C 反应蛋白和α-1 酸性糖蛋白(n=387)。我们使用线性回归估计均数差,使用校正聚类设计的修正泊松回归估计患病率比值。所有分析均采用意向治疗。
与对照组(T0)相比,LNS 组(T2 和 T3)儿童贫血和缺铁性贫血的患病率分别降低了约 40%和 25%,铁缺乏症的患病率分别降低了 25%(均<0.05)。与 T0 组相比,T4 组儿童的任何生物标志物均无差异;T3 组与 T2 组之间也无差异。
本研究结果表明,在大规模项目背景下提供 LNS 可显著改善幼儿的贫血和铁状况。本试验在 www.isrctn.com 注册,注册号为 ISRCTN81353066。